Clinical Trial Update: Upper GI Handling of Branded vs. Generic Alendronate [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating upper GI handling of branded Fosamax versus generic alendronate in osteoporosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• FOSAMAX (ALENDRONATE SODIUM)
• alendronate (alendronate)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED